TABLE 3.

Longitudinal evaluation of 31 M. genitalium culture-positive patients over a 17- to 39-month period of clinic visits

Patient no.	No. of mo enrolled	No. of visits analyzeda	ELISA rangeb	No. of visits positive by PCRc
6	26	9	0.01-0.15	1
23	22	3	0.03-0.10	0
26	25	6	0.02-0.10	3
31	25	5	0.08-0.17	0
13	32	9	0.07-0.27	2
25	27	8	0.07-0.57	3
14	29	8	0.07-0.31	2
15	20	6	0.10-0.19	2
22	30	9	0.07-0.40	0
12	25	5	0.13-0.30	0
4	23	7	0.10-0.31	1
9	35	12	0.10-0.60	3
29	24	10	0.06-0.47	2
16	29	11	0.14-0.29	2
10	23	8	0.09-0.30	2
30	24	4	0.10-0.38	1
2	33	5	0.17-0.46	1
5	31	9	0.31-0.74	3
17	21	6	0.31-0.49	3
21	26	8	0.23-0.80	6
19	24	4	0.23-0.42	1
7	22	4	0.11-0.41	0
1	17	4	0.25-0.42	0
3	21	9	0.12-0.47	1
11	28	9	0.06-0.56	3
24	24	9	0.33-1.02	2
27	23	5	0.34-1.24	1
28	28	9	0.17-0.65	6
8	39	7	0.36-0.87	1
18	23	4	0.53-0.93	2
20	27	3	0.52-1.56	1

^aNumber of visits analyzed, number of independent clinic visits during the evaluation period during which serum and vaginal and cervical specimens were obtained.

^bELISA range, lowest to highest values obtained, expressed as OD₄₀₅.

^cNumber positive by PCR, number of positive hybridizations from either vaginal or cervical samples, with the maximum number from a single visit equal to 1 (whether or not cervical and vaginal specimens were both positive).